NCT06480955View on ClinicalTrials.gov

BOne Metastases REgistry for Patients Undergoing cryoAbLation With curatIve purpoSe

Not yet recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

November 30, 2024

Primary Completion Date

November 30, 2027

Study Completion Date

November 30, 2027

Conditions
Bone Metastases
Interventions
DEVICE

Cryoablation system

Any cryoablation system from Boston Scientific that has received CE Mark and/or FDA clearance for the ablation of bone malignancies.

Sponsors
All Listed Sponsors
collaborator

Boston Scientific Corporation

INDUSTRY

lead

Cardiovascular and Interventional Radiological Society of Europe

OTHER